Everything you need to know about Chikungunya virus

Chikungunya virus (CHIKV) is a mosquito-borne viral disease that causes a sudden onset of fever and severe joint pain.

Although not usually life-threatening, it can lead to prolonged discomfort, making it an illness of significant public health concern in affected areas.

Origin

Chikungunya was first identified in Tanzania in 1952. The name “Chikungunya” comes from the Kimakonde language, meaning “that which bends up,” referring to the stooped posture of patients caused by intense joint pain.

Since its discovery, the virus has caused periodic outbreaks across Africa, Asia, the Americas, and islands in the Indian Ocean.

Causes and transmission

The virus belongs to the Alphavirus genus in the Togaviridaefamily.

Humans become infected primarily through the bites of infected Aedes aegypti and Aedes albopictu mosquitoes — the same species responsible for transmitting dengue and Zika viruses.

Primary source: Infected mosquitoes acquire the virus when they bite an infected person.

Secondary spread: Once infected, the mosquito can transmit the virus to other humans during feeding.

Human-to-human transmission: This does not occur directly; it requires a mosquito vector.

Symptoms and signs

The incubation period is typically 3–7 days after being bitten by an infected mosquito. Common symptoms include:

• Sudden high fever
• Severe joint pain (often in hands, wrists, ankles, or knees)
• Muscle aches
• Headache
• Fatigue
• Rash

Joint pain can last for weeks or even months, especially in older patients.

Complications

While chikungunya is rarely fatal, complications can occur, particularly in newborns, the elderly, and individuals with underlying health conditions. Severe cases may involve:

Eye inflammation

Neurological disorders (e.g., encephalitis)

Heart problems (e.g., myocarditis)

Diagnosis

Because chikungunya symptoms overlap with those of dengue and Zika, diagnosis often requires laboratory testing. Methods include:

RT-PCR: Detects viral RNA in early stages.

Serological tests: Identify antibodies (IgM/IgG) in later stages.

Treatment

Currently, there is no specific antiviral medication for chikungunya. Management focuses on relieving symptoms:

Adequate rest

Drinking plenty of fluidsPain relief using paracetamol (avoid aspirin and non-steroidal anti-inflammatory drugs until dengue is ruled out, to prevent bleeding risks)

Prevention

Since no licensed vaccine exists yet, prevention relies on avoiding mosquito bites and reducing mosquito populations:

• Wear long-sleeved clothing and trousers.
• Use insect repellents containing DEET, picaridin, or IR3535.
• Sleep under insecticide-treated mosquito nets.

Eliminate stagnant water where mosquitoes breed (e.g., flowerpots, discarded tires, buckets).